Claro Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Claro Advisors's EW Position: Q3 2023 in Review
Claro Advisors sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 5,480 shares — an estimated $517K sold.
Claro Advisors first reported a position in EW in Q4 2018 and held it in 18 quarters. The position peaked at $829K in Q4 2021. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.
- Claro Advisors reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
- Claro Advisors sold 5,480 Edwards Lifesciences shares in Q3 2023, an estimated $517K.
- Claro Advisors first reported a position in Edwards Lifesciences in Q4 2018 and held it in 18 quarters.
- Claro Advisors's Edwards Lifesciences position peaked at $829K in Q4 2021.
- 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.
Based on Claro Advisors's 13F filing for Q3 2023, filed 10 Oct 2023.